Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Tonix Pharmaceuticals Announces Presentation at the Rare Disease Innovation and Partnership Summit
Thursday, March 16, 2023Tonix Pharmaceuticals Holding Corp a clinicalstage biopharmaceutical company today announced that Herbert Harris MD PhD Executive Vice President Translational Medicine of Tonix Pharmaceuticals will deliver a presentation at the Rare Disease Innovatio...
Remedium Bio and Biovian have agreed to collaborate on Remedium’s first-in- class disease modifying AAV gene therapy for Osteoarthritis
Thursday, March 16, 2023Remedium Bio a Bostonarea gene therapy company developing treatments for a range of large clinical unmet needs in rheumatology endocrinology and agerelated diseases and Biovian Oy a globally operating Nordic CDMO for biopharmaceuticals have agreed on...
InDex Pharmaceuticals announces positive results from a pharmacokinetic (PK) study with cobitolimod
Wednesday, March 15, 2023InDex Pharmaceuticals Holding AB publ today announced positive results from a pharmacokinetic PK study with cobitolimod in patients with moderate to severe ulcerative colitis The systemic uptake was limited both for patients with active disease and i...
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
Wednesday, March 15, 2023The Janssen Pharmaceutical Companies of Johnson Johnson Janssen announced today the publication of new data in the journal Nature showing that an earlystage clinical candidate JNJ provides strong protection against dengue in nonhuman primates and mi...
Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years
Tuesday, March 14, 2023Pfizer Inc and BioNTech SE announced today that the US Food and Drug Administration FDA granted emergency use authorization EUA to provide a single booster dose of the companies Omicron BABAadapted bivalent COVID vaccine in children months through...
Culture Biosciences Focuses Technology and Service Platform on Biologics
Tuesday, March 14, 2023Culture Biosciences today announced that it is increasing its focus on upstream bioprocess development of new therapeutics New leaders for Operations and Commercial Engineering and Product Strategy and Finance and People enhance Culture Biosciences e...
NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP
Monday, March 13, 2023NeoGenomics Inc a leading provider of oncology testing and global contract research services announced today the expansion of their nextgeneration sequencing NGS portfolio of innovative products with the commercial availability of multiple tests incl...
Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial
Monday, March 13, 2023Mersana Therapeutics Inc a clinicalstage biopharmaceutical company focused on discovering and developing a pipeline of antibodydrug conjugates ADCs targeting cancers in areas of high unmet medical need
Richard Stedman rejoins ACG as the CEO of Engineering Division
Friday, March 10, 2023ACG a leading supplier of integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries is pleased to announce that Richard Stedman will be rejoining the business as the Group CEO of the Engineering division Richard is...
Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics
Friday, March 10, 2023Alnylam Pharmaceuticals Inc the leading RNAi therapeutics company and Medison Pharma Medison a global pharma company focused on providing access to highly innovative therapies for patients in international markets have announced an expansion of their...
